Organon & Co (OGN) USD0.01

Sell:$14.30Buy:$14.74$0.59 (4.18%)

Prices delayed by at least 15 minutes
Sell:$14.30
Buy:$14.74
Change:$0.59 (4.18%)
Deal now
Prices delayed by at least 15 minutes
Sell:$14.30
Buy:$14.74
Change:$0.59 (4.18%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.

Key people

Kevin Ali
Chief Executive Officer, Director
Matthew M. Walsh
Chief Financial Officer, Executive Vice President
Aaron Falcione
Chief Human Resource Officer, Executive Vice President
Rachel A. Stahler
Executive Vice President, Chief Information Officer
Kirke Weaver
Executive Vice President, General Counsel, Corporate Secretary
Juan Camilo Arj Ferreira
Executive Vice President, Head of Research and Development and Chief Medical Officer
Joseph T. Morrissey
Executive Vice President, Head of Manufacturing and Supply
Vittorio Nisita
Executive Vice President, Head of Global Business Services
Carrie S. Cox
Independent Chairman of the Board
Robert A. Essner
Independent Director
Alan Ezekowitz
Independent Director
Helene D. Gayle
Independent Director
Rochelle B. Lazarus
Independent Director
Click to see more

Key facts

  • EPIC
    OGN
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US68622V1061
  • Market cap
    $3.84bn
  • Employees
    10,000
  • Shares in issue
    257.95m
  • Exchange
    New York Stock Exchange
  • Index
    S&P 600 Small Cap, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.